| Heading: |
Respiratory Syncytial Virus: Vaccination |
| Question ID: |
1815220 |
| UIN: |
HL8729 |
| House: |
Lords |
| Date tabled: |
2025-06-23 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of the merits of extending eligibility for the respiratory syncytial virus vaccine to include people over 80 years old, clinical risk groups and immunocompromised people. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-07 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
During the Joint Committee on Vaccination and Immunisation’s (JCVI) meeting of the 5 February 2025, the Department confirmed that any extension to those aged 80 years old and over would require an analysis of both impact and cost effectiveness. JCVI state... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |